Skip to main content
Top
Published in: International Ophthalmology 11/2020

01-11-2020 | Laser | Original Paper

Risk factors associated with avascular fibrous membrane in patients with retinopathy of prematurity

Authors: Emrah Utku Kabatas, Serdar Ozates

Published in: International Ophthalmology | Issue 11/2020

Login to get access

Abstract

Purpose

We sought to assess the risk factors associated with avascular fibrous membrane development in patients with retinopathy of prematurity (ROP).

Methods

This retrospective, cross-sectional study included premature infants diagnosed with ROP. Gestational age, birth weight, stage and zone of the ROP, the presence of plus disease, and laser photocoagulation (LP) application were noted for each patient. Location, extension, development time, vanishing time of the avascular fibrous membrane, and associated complications were also noted. Patients who developed avascular fibrous membrane formed the membrane group (n = 38) and those who did not develop avascular fibrous membrane formed the control group (n = 208).

Results

Mean gestational age and birth weight did not differ between the groups (p = 0.897 and p = 0.343). ROP developed significantly earlier in the control group than in the membrane group (p < 0.001). The patients in the control group underwent LP treatment significantly earlier than did patients in the membrane group (p < 0.001). Regression analysis showed that higher postmenstrual age at the time of ROP diagnosis increased the risk of avascular fibrous membrane development by up to 1.6-fold (p = 0.002; 95% CI 1.2–2.3) and later LP treatment was associated with a 3.3-fold increased risk of avascular fibrous membrane development (p = 0.003; 95% CI 1.5–7.3).

Conclusions

Late-onset ROP and later LP treatment were found to be associated with an increased risk of avascular fibrous membrane development in patients with ROP.
Literature
1.
go back to reference Ophthalmology AAoPSo (2013) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 131:189–195CrossRef Ophthalmology AAoPSo (2013) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 131:189–195CrossRef
2.
go back to reference Good WV, Early Treatment for Retinopathy of Prematurity Cooperative G (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233–248 (discussion 248–250)PubMedPubMedCentral Good WV, Early Treatment for Retinopathy of Prematurity Cooperative G (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233–248 (discussion 248–250)PubMedPubMedCentral
3.
go back to reference Sood BG, Madan A, Saha S, Schendel D, Thorsen P, Skogstrand K, Hougaard D, Shankaran S, Carlo W (2010) Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 67:394–400CrossRef Sood BG, Madan A, Saha S, Schendel D, Thorsen P, Skogstrand K, Hougaard D, Shankaran S, Carlo W (2010) Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 67:394–400CrossRef
4.
go back to reference Mutlu FM, Sarici SU (2013) Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol 6:228–236PubMedPubMedCentral Mutlu FM, Sarici SU (2013) Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol 6:228–236PubMedPubMedCentral
5.
go back to reference Zhao S, Overbeek PA (2001) Elevated TGFbeta signaling inhibits ocular vascular development. Dev Biol 237:45–53CrossRef Zhao S, Overbeek PA (2001) Elevated TGFbeta signaling inhibits ocular vascular development. Dev Biol 237:45–53CrossRef
6.
go back to reference Beranek M, Kankova K, Benes P, Izakovicova-Holla L, Znojil V, Hajek D, Vlkova E, Vacha J (2002) Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 109:278–283CrossRef Beranek M, Kankova K, Benes P, Izakovicova-Holla L, Znojil V, Hajek D, Vlkova E, Vacha J (2002) Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 109:278–283CrossRef
7.
go back to reference Group ETfRoPC (2006) Thef54098structural findings at age 2 years. Br J Ophthalmol 90:1378CrossRef Group ETfRoPC (2006) Thef54098structural findings at age 2 years. Br J Ophthalmol 90:1378CrossRef
8.
go back to reference Terasaki H, Hirose T (2003) Late-onset retinal detachment associated with regressed retinopathy of prematurity. Jpn J Ophthalmol 47:492–497CrossRef Terasaki H, Hirose T (2003) Late-onset retinal detachment associated with regressed retinopathy of prematurity. Jpn J Ophthalmol 47:492–497CrossRef
9.
go back to reference Lee BJ, Kim JH, Heo H, Yu YS (2012) Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity. Eye (Lond) 26:903–909 (quiz 910)CrossRef Lee BJ, Kim JH, Heo H, Yu YS (2012) Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity. Eye (Lond) 26:903–909 (quiz 910)CrossRef
10.
go back to reference Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N (2016) Retinopathy of prematurity: Past, present and future. World J Clin Pediatr 5:35–46CrossRef Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N (2016) Retinopathy of prematurity: Past, present and future. World J Clin Pediatr 5:35–46CrossRef
11.
go back to reference Lee AC, Maldonado RS, Sarin N, O’Connell RV, Wallace DK, Freedman SF, Cotten M, Toth CA (2011) Macular features from spectral domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina 31:1470CrossRef Lee AC, Maldonado RS, Sarin N, O’Connell RV, Wallace DK, Freedman SF, Cotten M, Toth CA (2011) Macular features from spectral domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina 31:1470CrossRef
12.
go back to reference Zepeda EM, Shariff A, Gillette TB, Grant L, Ding L, Tarczy-Hornoch K, Cabrera MT (2018) Vitreous bands identified by handheld spectral-domain optical coherence tomography among premature infants. JAMA Ophthalmol 136:753–758CrossRef Zepeda EM, Shariff A, Gillette TB, Grant L, Ding L, Tarczy-Hornoch K, Cabrera MT (2018) Vitreous bands identified by handheld spectral-domain optical coherence tomography among premature infants. JAMA Ophthalmol 136:753–758CrossRef
Metadata
Title
Risk factors associated with avascular fibrous membrane in patients with retinopathy of prematurity
Authors
Emrah Utku Kabatas
Serdar Ozates
Publication date
01-11-2020
Publisher
Springer Netherlands
Keyword
Laser
Published in
International Ophthalmology / Issue 11/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-020-01484-4

Other articles of this Issue 11/2020

International Ophthalmology 11/2020 Go to the issue